Lombard Medical Company Profile (NASDAQ:EVAR)

About Lombard Medical

Lombard Medical logoLombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company's Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The Company supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. It also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EVAR
  • CUSIP:
Key Metrics:
  • Previous Close: $0.63
  • 50 Day Moving Average: $0.6305
  • 200 Day Moving Average: $0.8074
  • 52-Week Range: $0.50 - $1.94
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.62
  • P/E Growth: -0.0100
  • Market Cap: $12.52M
  • Outstanding Shares: 19,885,000
  • Beta: 1.42
Profitability:
  • Net Margins: -274.92%
  • Return on Equity: -115.39%
  • Return on Assets: -47.38%
Debt:
  • Debt-to-Equity Ratio: 1.33%
  • Current Ratio: 2.35%
  • Quick Ratio: 1.52%
Additional Links:
Companies Related to Lombard Medical:

Analyst Ratings

Consensus Ratings for Lombard Medical (NASDAQ:EVAR) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.00 (58.86% upside)

Analysts' Ratings History for Lombard Medical (NASDAQ:EVAR)
Show:
DateFirmActionRatingPrice TargetDetails
8/23/2016BTIG ResearchReiterated RatingHoldView Rating Details
8/23/2016Barclays PLCLower Price TargetEqual Weight$2.50 -> $1.00View Rating Details
7/28/2015Jefferies Group LLCLower Price TargetBuy$7.50 -> $6.00View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Lombard Medical (NASDAQ:EVAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/20/2017        
8/22/2016Q2145($0.40)($0.42)$3.78 million$3.80 millionViewListenView Earnings Details
5/11/2016Q1($0.41)($0.38)$3.52 million$2.90 millionViewListenView Earnings Details
2/22/2016Q415($0.40)($0.58)$3.25 million$2.94 millionViewListenView Earnings Details
11/4/2015Q315($0.53)($0.45)$4.65 million$4.20 millionViewN/AView Earnings Details
7/27/2015Q215($0.55)($0.51)$4.46 million$4.54 millionViewListenView Earnings Details
5/11/2015Q1145($0.57)($0.59)$3.20 million$3.41 millionViewListenView Earnings Details
2/26/2015Q4($0.58)($0.51)$4.80 million$4.80 millionViewN/AView Earnings Details
10/29/2014Q314($0.79)($0.52)$2.14 million$4.30 millionViewN/AView Earnings Details
8/11/2014($0.52)($0.86)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Lombard Medical (NASDAQ:EVAR)
Current Year EPS Consensus Estimate: $-1.4500 EPS
Next Year EPS Consensus Estimate: $-1.0200 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.49)($0.39)($0.44)
Q2 20162($0.40)($0.39)($0.40)
Q3 20162($0.39)($0.32)($0.36)
Q4 20162($0.41)($0.31)($0.36)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Lombard Medical (NASDAQ:EVAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Lombard Medical (NASDAQ:EVAR)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Lombard Medical (NASDAQ:EVAR)
DateHeadline
News IconAdvanced Global EVAR Market To Be Propelled By Increasing Use Of Percutaneous EVAR By Medical Practitioners (NASDAQ:EVAR)
empowerednews.net - February 7 at 11:18 PM
finance.yahoo.com logoLombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft (NASDAQ:EVAR)
au.finance.yahoo.com - February 7 at 6:17 PM
sbwire.com logoGlobal Aortic Aneurysm Repair Devices Market Is Expected to Reach $3,448.2 Million by 2023; Finds New Report (NASDAQ:EVAR)
www.sbwire.com - January 19 at 3:32 AM
News IconIQ4I Research & Consultancy Published a New Report on "Aortic Aneurysm Repair Devices Global Market – Forecast to 2023" (NASDAQ:EVAR)
www.pr.com - January 9 at 5:51 PM
us.rd.yahoo.com logoLombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft (NASDAQ:EVAR)
us.rd.yahoo.com - January 6 at 5:37 PM
News IconLombard Medical's IntelliFlex LP Delivery System for the Aorfix EVAR System Approved in Japan (NASDAQ:EVAR)
evtoday.com - January 5 at 5:53 PM
News IconLombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aort... (NASDAQ:EVAR)
ih.advfn.com - January 5 at 5:53 PM
finance.yahoo.com logoEVAR: $15M Investment, Additional Positive Outcomes Data (NASDAQ:EVAR)
finance.yahoo.com - December 23 at 5:19 PM
4-traders.com logoMicroPort Scientific : MPSC and Lombard Medical Announce Strategic Partnership and Inve... (NASDAQ:EVAR)
www.4-traders.com - December 21 at 5:53 PM
publicnow.com logoMPSC and Lombard Medical Announce Strategic Partnership and Inve... (NASDAQ:EVAR)
www.publicnow.com - December 20 at 10:04 AM
benzinga.com logoPositive Long-Term Data for Lombard Medical'... (NASDAQ:EVAR)
www.benzinga.com - December 5 at 5:44 PM
News IconFive-Year PYTHAGORAS Data Presented for Lombard Medical's Aorfix EVAR System (NASDAQ:EVAR)
evtoday.com - December 5 at 5:44 PM
us.rd.yahoo.com logoPositive Long-Term Data for Lombard Medical’s Aorfix™ Endovascular Stent Graft System Confirms Sustained Performance in the Most Challenging Anatomies (NASDAQ:EVAR)
us.rd.yahoo.com - December 5 at 11:44 AM
us.rd.yahoo.com logo6:01 am Lombard Medical announces 'positive' long-term data for its Aorfix endovascular stent graft system at the VEITHsymposium (NASDAQ:EVAR)
us.rd.yahoo.com - December 5 at 11:44 AM
News IconData Presented From Early Experience With Lombard Medical’s Altura EVAR System (NASDAQ:EVAR)
evtoday.com - November 22 at 10:35 PM
globenewswire.com logoUK - Manchester Group of Hospitals presented early experience and 100% technical success in 24 patients treated with Altura (NASDAQ:EVAR)
globenewswire.com - November 22 at 8:08 AM
streetinsider.com logoForm 6-K Lombard Medical, Inc. For: Nov 21 (NASDAQ:EVAR)
www.streetinsider.com - November 22 at 8:08 AM
publicnow.com logoMulti-Centre Early Experience and Data Presented on Lombard Medical’s Altura® Endovascular Stent Graft at the 43rd Annual VEITHsymposium™ (NASDAQ:EVAR)
www.publicnow.com - November 21 at 5:10 PM
streetinsider.com logoLombard Medical (EVAR) Receives Nasdaq Listing Notification (NASDAQ:EVAR)
www.streetinsider.com - November 16 at 5:05 PM
publicnow.com logoLombard Medical Receives NASDAQ Notice of Bid Price Deficiency (NASDAQ:EVAR)
www.publicnow.com - November 15 at 5:23 PM
publicnow.com logoLombard Medical Announces Scientific Presentations on Aorfix™ and Altura® Endovascular Stent Grafts at the 43nd Annual VEITHsymposium™ (NASDAQ:EVAR)
www.publicnow.com - November 14 at 8:50 AM
finance.yahoo.com logoEVAR: Benefits From IntelliFlex, Sales Reorg Not Yet Fully Realized (NASDAQ:EVAR)
finance.yahoo.com - November 1 at 5:05 PM
capitalcube.com logoLombard Medical, Inc. :EVAR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016 (NASDAQ:EVAR)
www.capitalcube.com - October 31 at 4:59 PM
sg.finance.yahoo.com logoLombard Medical reports 3Q loss (NASDAQ:EVAR)
sg.finance.yahoo.com - October 28 at 8:01 AM
publicnow.com logoLombard Medical Reports 2016 Third Quarter, Nine-Month Financial Results (NASDAQ:EVAR)
www.publicnow.com - October 27 at 4:58 PM
News IconGlobal Endovascular Aneurysm Repair (EVAR) Market To Be Propelled By Increasing Use Of Percutaneous EVAR By Medical Practitioners (NASDAQ:EVAR)
www.medgadget.com - October 21 at 4:57 PM
finance.yahoo.com logoEVAR: Exiting Underperforming U.S. Market and Seeking 'Strategic Alternatives' (NASDAQ:EVAR)
finance.yahoo.com - August 24 at 4:51 PM
News IconLombard Medical Eliminates U.S. Sales Force After FDA Decision (NASDAQ:EVAR)
www.biospace.com - August 23 at 10:00 PM
finance.yahoo.com logoEdited Transcript of EVAR earnings conference call or presentation 22-Aug-16 8:30pm GMT (NASDAQ:EVAR)
finance.yahoo.com - August 23 at 9:15 AM
sg.finance.yahoo.com logoLombard Medical reports 2Q loss (NASDAQ:EVAR)
sg.finance.yahoo.com - August 22 at 4:59 PM
publicnow.com logoLombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives (NASDAQ:EVAR)
www.publicnow.com - August 22 at 4:59 PM
biz.yahoo.com logoQ2 2016 Lombard Medical Inc Earnings Release - After Market Close (NASDAQ:EVAR)
biz.yahoo.com - August 22 at 9:35 AM
baystreet.ca logoDurable Goods, Wholesale Trade, on Next Week’s Docket (NASDAQ:EVAR)
www.baystreet.ca - August 19 at 4:52 PM
nasdaq.com logoLombard Medical Reschedules 2016 Second Quarter, Six-Month Financial Results Release and Conference (NASDAQ:EVAR)
www.nasdaq.com - August 12 at 4:57 PM
publicnow.com logoLombard Medical Reschedules 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date to August 22 to Provide Complete Information on Operational Initiatives (NASDAQ:EVAR)
www.publicnow.com - August 12 at 4:57 PM
publicnow.com logoLombard Medical Announces 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date (NASDAQ:EVAR)
www.publicnow.com - August 8 at 9:42 AM
publicnow.com logoLombard Medical Expands European Launch of its New Altura® Endograft System (NASDAQ:EVAR)
www.publicnow.com - July 6 at 6:11 AM
globenewswire.com logoIntelliFlex LP’s Lower Catheter Profile Expands Aorfix Treatment to More Patients (NASDAQ:EVAR)
globenewswire.com - July 1 at 4:54 PM
nasdaq.com logoIntelliFlex LP's Lower Catheter Profile Expands Aorfix Treatment to More Patients (NASDAQ:EVAR)
www.nasdaq.com - June 30 at 10:22 PM
globenewswire.com logoLombard Medical Announces First Commercial Use of its New IntelliFlex™ LP Delivery System for the Aorfix ... - GlobeNewswire (press release) (NASDAQ:EVAR)
globenewswire.com - June 30 at 7:30 AM
publicnow.com logoLombard Medical Announces First Commercial Use of its New IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft (NASDAQ:EVAR)
www.publicnow.com - June 30 at 6:11 AM
kcregister.com logoToday's Stocks: Lombard Medical, Inc. (NASDAQ:EVAR), Oracle Corporation (NYSE:ORCL), Autohome Inc. (NYSE ... - KC Register (NASDAQ:EVAR)
www.kcregister.com - June 28 at 9:55 PM
globenewswire.com logoNew, Innovative Design Enhances Control and Precision During Placement with the Potential to Reduce Vessel Trauma (NASDAQ:EVAR)
globenewswire.com - June 20 at 4:47 PM
publicnow.com logoLombard Medical Announces CE Mark Approval for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft (NASDAQ:EVAR)
www.publicnow.com - June 20 at 12:39 PM
globenewswire.com logoPaul Hayes, MD, FRCS, Endovascular Surgeon, University of Cambridge and Addenbrookes Hospital, Appointed as Principal Investigator (NASDAQ:EVAR)
globenewswire.com - June 16 at 9:16 AM
publicnow.com logoLombard Medical to Initiate the Altura® ALTITUDE Global Registry to Evaluate the Treatment of Abdominal Aortic Aneurysms Across a Wide Range of “Real-World” Endovascular Aneurysm Repair Interventions (NASDAQ:EVAR)
www.publicnow.com - June 16 at 8:39 AM
publicnow.com logoLombard Medical Reports Positive Five-Year Aorfix™ Endovascular Stent Graft Clinical Results in AAA Patients with Challenging Anatomy (NASDAQ:EVAR)
www.publicnow.com - June 13 at 6:09 AM
streetinsider.com logoLombard Medical (EVAR) Offers Commercial Update on Altura Endovascular Stent Graft System (NASDAQ:EVAR)
www.streetinsider.com - June 9 at 8:27 AM
finance.yahoo.com logo6:10 am Lombard Medical provides update on Altura Endovascular Stent Graft System, EU launch planned in 3Q16, long-term clinical data to be released in second half of 2016 (NASDAQ:EVAR)
finance.yahoo.com - June 8 at 6:10 AM
publicnow.com logoLombard Medical Provides Update on Controlled Launch of the New Altura® Endovascular Stent Graft in Europe (NASDAQ:EVAR)
www.publicnow.com - June 8 at 6:08 AM

Social

What is Lombard Medical's stock symbol?

Lombard Medical trades on the NASDAQ under the ticker symbol "EVAR."

Where is Lombard Medical's stock going? Where will Lombard Medical's stock price be in 2017?

2 equities research analysts have issued 1 year target prices for Lombard Medical's stock. Their forecasts range from $1.00 to $1.00. On average, they expect Lombard Medical's share price to reach $1.00 in the next twelve months.

When will Lombard Medical announce their earnings?

Lombard Medical is scheduled to release their next quarterly earnings announcement on Monday, February, 20th 2017.

Who owns Lombard Medical stock?

Lombard Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include /(Entity Only) MicroPort Scientific Corporation (40.98%), MicroPort Scientific Corporation (40.98%), SV Life Sciences Advisers LLC (6.42%) and New Leaf Venture Partners L.L.C. (5.39%).

Who bought Lombard Medical stock? Who is buying Lombard Medical stock?

Lombard Medical's stock was acquired by a variety of institutional investors in the last quarter, including New Leaf Venture Partners L.L.C..

How do I buy Lombard Medical stock?

Shares of Lombard Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Lombard Medical stock cost?

One share of Lombard Medical stock can currently be purchased for approximately $0.63.

Lombard Medical (NASDAQ:EVAR) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Lombard Medical (NASDAQ:EVAR)

Earnings History Chart

Earnings by Quarter for Lombard Medical (NASDAQ:EVAR)

Dividend History Chart

Dividend Payments by Quarter for Lombard Medical (NASDAQ:EVAR)

Last Updated on 2/21/2017 by MarketBeat.com Staff